NewsBenzingaJP Morgan Initiates Coverage On C4 Therapeutics with Overweight Rating, Announces Price Target of $10 JP Morgan Initiates Coverage On C4 Therapeutics with Overweight Rating, Announces Price Target of $10 Benzinga 2026.10.09 19:05 (GMT+0) Open on Benzinga Other news Goodyear Tire & Rubber Appoints Joe Hinrichs Board Chairman, Effective Oct. 7, Succeeding LauretteKoellner Here’s How Much You Would Have Made Owning AbbVie Stock In The Last 5 Years Ryde Group Files For Up To $96.399M Offering Of Class A Shares JP Morgan Maintains Neutral on Steel Dynamics, Lowers Price Target to $260 JP Morgan Maintains Overweight on SPX Technologies, Lowers Price Target to $225 Blackstone Raises $1 Billion For Private Credit Continuation Fund As Secondaries Boom
Goodyear Tire & Rubber Appoints Joe Hinrichs Board Chairman, Effective Oct. 7, Succeeding LauretteKoellner
